Dutch biotech company NorthSea Therapeutics collects Series A funding
NorthSea Therapeutics B.V., a Dutch biotech company, has closed 25 million euros in Series A funding. Forbion and BGV led the round with participation from Novo Seeds and New Science Ventures.
13 December 2017•1 min read
